List of insiders holdings for PMV Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC 10% Owner | 2023-08-23 16:56:54 | 6,563,077 0 | 6,563,077 | Form 13D |
| ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC OrbiMed Genesis GP LLC 10% Owner | 2023-11-24 16:38:04 | 0 6,475,291 | 6,475,291 | Form 4 |
| ORONSKY ARNOLD L Director 10% Owner | 2020-10-02 18:42:47 | 0 6,469,911 | 6,469,911 | Form 4/A |
| Euclidean Capital LLC Greenland A LLC Greenland FP LLC Greenland NFP B Ltd. Greenland NFP LLC Symmetry Group Ltd. Simons Marilyn Chhabra Ashvin SIMONS JAMES H 10% Owner | 2022-02-14 07:17:29 | 2,336,909 0 | 2,336,909 | Form 13G |
| INTERWEST PARTNERS X LP InterWest Management Partners X LLC NASR KHALED Desai Keval Kliman Gilbert H 10% Owner | 2023-02-10 13:00:54 | 1,714,540 0 | 1,714,540 | Form 13G |
| RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner | 2020-09-29 16:30:24 | 0 1,710,265 | 1,710,265 | Form 4 |
| Nextech V Oncology S.C.S. SICAV-SIF NEXTECH V GP S.A R.L. Bleyer Dalia Lips Thomas Detournay Philippe Former 10% Owner | 2022-02-14 16:00:26 | 1,385,807 0 | 1,385,807 | Form 13G |
| Schroeder Thilo Director | 2021-10-08 17:57:47 | 0 1,101,283 | 1,101,283 | Form 4 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. Former 10% Owner | 2020-09-29 16:48:42 | 760,267 0 | 760,267 | Form 4 |
| Mack David Henry President and CEO | 2024-10-03 16:44:08 | 714,184 0 | 714,184 | Form 4 |
| Jalota Deepika Chief Development Officer | 2024-10-03 16:50:25 | 215,774 0 | 215,774 | Form 4 |
| Carulli Michael Chief Financial Officer | 2024-10-03 16:48:44 | 190,805 0 | 190,805 | Form 4 |
| Kung Winston COO, CFO | 2023-05-15 17:56:13 | 150,000 0 | 150,000 | Form 4 |
| Gallagher Carol Giltner Director | 2024-06-10 16:21:10 | 67,500 67,500 | 135,000 | Form 4 |
| BAUM CHARLES M Director | 2024-06-10 16:15:37 | 67,500 0 | 67,500 | Form 4 |
| FLOWERS KIRSTEN Director | 2024-06-10 16:17:57 | 67,500 0 | 67,500 | Form 4 |
| Heyman Richard A. Director | 2024-06-10 16:22:51 | 67,500 0 | 67,500 | Form 4 |
| LEVINE ARNOLD J Director | 2024-06-10 16:43:24 | 67,500 0 | 67,500 | Form 4 |
| Stelzer Laurie Director | 2024-06-10 16:44:40 | 67,500 0 | 67,500 | Form 4 |
| Alland Leila Chief Medical Officer | 2023-09-18 16:22:58 | 45,909 0 | 45,909 | Form 4 |
| Thompson Peter A. Director 10% Owner | 2021-06-09 17:41:40 | 16,333 0 | 16,333 | Form 4 |
| Double Epiphany LLC Former 10% Owner | 2020-09-29 16:45:45 | 0 0 | 0 | Form 4 |
| Levine Alison Former 10% Owner | 2020-09-29 16:44:43 | 0 0 | 0 | Form 4 |
| Dawson Samantha Former 10% Owner | 2020-09-29 16:43:51 | 0 0 | 0 | Form 4 |
| Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. Former 10% Owner | 2024-02-14 16:02:17 | 0 0 | 0 | Form 13G |